Healthcare Private Placement and M&A Transactions Review Week Ending May 8 2022

Hello Heart: The company raised $70.00 million of Series D venture funding in a deal led by Stripes on May 2, 2022, putting the company’s pre-money valuation at $530.00 million. Resolute Ventures, Maven Ventures, BlueRun Ventures, Khosla Ventures, IVP, and other undisclosed investors also participated in the round. The company is a developer of a health monitoring system designed to facilitate self-health diagnosis.

Tubulis: The company raised EUR 60 million of Series B venture funding in a deal led by Andera Partners on May 3, 2022, putting the company’s pre-money valuation at an estimated EUR 45.4 million. Fund+ and 7 other investors also participated in the round. The company is a developer of chemotherapeutic drugs designed to fight against cancer and chronic diseases.

Apnimed: The company raised $62.5 million through the combination of Series C-1 and Series C-2 venture funding in a deal led by Sectoral Asset Management on May 4, 2022, putting the company’s pre-money valuation at $208 million. Seligman Technology Group, Alpha Wave Global, Tao Capital Partners, Morningside Group, NexPoint, and other undisclosed investors also participated in the round. The company is a developer of a pharmacologic therapy designed to treat people who are affected by sleep apnea and related disorders.

Healthmap Solutions: The company received $35 million of development capital from GuideWell Mutual Holding, Diamond Castle Holdings, WindRose Health Investors, Shulman Ventures and Highmark Health Ventures on May 2, 2022. The company is a provider of clinical and data analytics services intended to improve the clinical care and financial performance of high-risk, high-cost kidney patient populations.

Aerin Medical: The company raised $34.9 million of venture funding from Ally Bridge Group and Murphree Venture Partners on May 3, 2022. The company is a developer of non-invasive treatment device designed to improve symptoms of nasal breathing disorders.

Biolog-id: The company raised $25 million of venture funding from Xerys Invest on May 5, 2022. The company is a developer of digital health solutions focused on value-chain optimization.

PatientIQ: The company raised $17.5 million of Series B venture funding from Health Enterprise Partners and other undisclosed investors on May 2, 2022, putting the company’s pre-money valuation at $63 million. The company is an operator of a cloud-based platform for healthcare services intended to improve patient outcomes.

Enumera Molecular: The company raised $12.5 million of Series A venture funding in a deal led by Arboretum Ventures on May 5, 2022. The company is an operator of a life science tools company intended to develop a scalable biomolecule assessment platform.

Versono Medical: The company raised EUR 6.7 million of venture funding from WDC, Enterprise Ireland and Business Venture Partners on May 3, 2022. DHKN also participated in the round. The company is a manufacturer of a medical device for intravascular treatment for CLI (Critical Limb Ischemia) Patients.

AnimalBiome: The company raised $5.5 million of Series A3 venture funding from undisclosed investors on May 3, 2022, putting the company’s pre-money valuation at $34.5 million. The company is a developer of microbiome-based diagnostics and therapeutics for pets, intended to help identify gut biome imbalances and provide tailored supplements to improve gut health.

Fifth Eye: The company raised $5.4 million of venture funding in the form of convertible promissory notes from undisclosed investors on May 5, 2022. The company is a developer of a real-time predictive analytics technology designed to analyze hemodynamic instability.

Zoan Biomed: The company raised EUR 5 million of venture funding from undisclosed investors on May 3, 2022. The company is a developer of bio coral bone graft therapies designed to develop orthobiologic scaffolds.

Virtual Health Partners: The company raised $3.5 million of Series B venture funding from undisclosed investors on May 6, 2022. The company is a provider of an on-demand patient care platform intended to focus on ancillary care treatment.

CytoSPAR: The company raised $3 million of Series A and Series A1 venture funding from KittyHawk Ventures and other undisclosed investors on May 3, 2022. The company is a developer and provider of diagnostic and therapeutic platforms designed to detect deadly viruses and bacteria.

---

In2Bones / Conmed: The company reached a definitive agreement to be acquired by Conmed for $145 million on May 4, 2022. The company is an operator of an orthopedic business intended to produce implants and instrumentation for the upper and lower extremities.

Allegro 3D / BICO Group: The company was acquired by BICO Group for $11 million on May 5, 2022. The company is an operator of a 3D printing and bioprinting platform intended to accelerate the development of tissue models for drug screening and regenerative medicine.

ALung / LivaNova: The company was acquired by LivaNova for $10 million on May 2, 2022. The company is a developer of a respiratory assist and dialysis system designed for the treatment of acute and chronic respiratory disorders.

NeighborMD Management / Skylight Health Group: The company was acquired by Skylight Health Group for $8 million on May 6, 2022. The company is an operator of medical and health clinics based in Nashville.

Citagenix / HANSAmed: The company reached a definitive agreement to be acquired by HANSAmed for $6.75 million on May 2, 2022. The company is a manufacturer of a commercialized medical device for bone regeneration intended to supply grafting products to dental surgeons, periodontists and implant dentists.

Crispin Orthotics / Ability Matters Group: The company was acquired by Ability Matters Group for an undisclosed amount on May 6, 2022. The company is a developer of orthotic devices intended to focus on the design, production and use of orthoses.

DNAGO.Ai / Oncologix Tech: The company reached a definitive agreement to acquire Oncologix Tech through a reverse merger, resulting in the combined entity trading on the OTC Market under the ticker symbol OCLG on May 2, 2022. The company is a developer of clinical genetic testing kits for rare genetic diseases, including Cystic fibrosis, Fabry disease, Epilepsy, Hemophilia, and all types of hereditary cancers.

Fiagon / Hemostasis, LLC: The company reached a definitive agreement to be acquired by Hemostasis, LLC for an undisclosed amount on May 4, 2022. The company is a developer of clinical navigation systems designed to enhance image guidance by improving the function of electromagnetic navigation.

Greater Boston Home Health Care Services / Houseworks: The company was acquired by Houseworks, a subsidiary of RAB Ventures, for an undisclosed amount on May 4, 2022. The company is an operator of a healthcare agency intended to provide in-home care and personal care services.

Integra Managed Care / Anthem: The company, a subsidiary of Personal-Touch Home Care was acquired by Anthem for an undisclosed amount on May 5, 2022. The company is a provider of managed long-term care services designed for adults living with long-term disabilities.

IntralinkSpine / Spinal Simplicity: The company was acquired by Spinal Simplicity for an undisclosed amount on May 6, 2022. The company is a manufacturer of an injectable medical device intended to treat intervertebral disc degeneration and associated low back pain.

LSK Technologies / Nicoya Lifesciences: The company was acquired by Nicoya Lifesciences for an undisclosed amount on May 2, 2022. The company is a developer of a laboratory-grade diagnostic testing device designed to provide precise and quantitative results for biological and chemical reactions.

Magellan Health / Prime Therapeutics: The company reached a definitive agreement to be acquired by Prime Therapeutics for an undisclosed amount on May 5, 2022. Magellan Health provides healthcare management services to health plans and other managed care organizations, employers, labor unions, United States government agencies, and third-party administrators.

Modus Medical Devices / Ion Beam Applications: The company was acquired by Ion Beam Applications for an undisclosed amount on May 3, 2022. The company is a provider of instruments intended for the field of advanced radiotherapy and medical imaging.